[A case of advanced prostatic cancer in a 44-year-old treated effectively with combination chemo-endocrine therapy].
In a 44-year-old man with persistent back-pain for 3 months duration, radiological and echological investigations revealed prostatic mass lesion with multiple osteoblastic involvements. Transrectal biopsy to the prostate demonstrated pathohistologically poorly differentiated adenocarcinoma (Gleason's score 4-4:8). Serum ACP, ALP and IAP were elevated at the initial diagnosis pathologically. The clinical and pathological stage was D2, without metastasis to lung and liver. Combination chemo-endocrine therapy (methotrexate, adriamycin, pepleomycin, Estracyt and tegafur) with bilateral orchiectomies was performed exclusively as initial treatment. These consecutive treatments brought remarkable reduction of the prostatic mass lesion, decrease of tumor markers to normal range, rapid improvement of subjective symptoms and distinct decrease of abnormal activity in bone scintigram. More than 3 years survival was obtained, and normal performance-status was kept. Prostatic cancer in middle-aged adults is reviewed and discussed.
Araki
S
S
Department of Urology, Saitama Medical School.
Kusuyama
H
H
Kato
M
M
Okada
K
K
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000601:surgery; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D004961:Estramustine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D009919:Orchiectomy; D017663:Peplomycin; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000601:surgery; D012074:Remission Induction; D005641:Tegafur / Q000008:administration & dosage
D009588:Nitrogen Mustard Compounds; D001761:Bleomycin; D005641:Tegafur; D004961:Estramustine; D017663:Peplomycin; D004317:Doxorubicin; D008727:Methotrexate